Your browser doesn't support javascript.
loading
A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic.
Tiu, Crescens; Shinde, Rajiv; Yap, Christina; Rao Baikady, Bindumalini; Banerji, Udai; Minchom, Anna R; de Bono, Johann S; Lopez, Juanita S.
Affiliation
  • Tiu C; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK.
  • Shinde R; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK.
  • Yap C; Institute of Cancer Research's Clinical Trials and Statistics Unit, Sutton, UK.
  • Rao Baikady B; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK.
  • Banerji U; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK.
  • Minchom AR; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK.
  • de Bono JS; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK.
  • Lopez JS; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK. Electronic address: Juanita.Lopez@icr.ac.uk.
Lancet Oncol ; 21(7): 889-891, 2020 07.
Article in En | MEDLINE | ID: mdl-32615107

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Clinical Trials, Phase I as Topic / Coronavirus Infections / Neoplasms Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Clinical Trials, Phase I as Topic / Coronavirus Infections / Neoplasms Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Country of publication: